piposulfan

Also Known As:

1,4-bis(3-((methylsulfonyl)oxy)-1-oxopropyl)piperazine; nano-piposulfan

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/1997 - "Nine agents were evaluated IV against early stage subcutaneous PC-3 tumors, with Nano-piposulfan being the only agent highly active (4.9 log kill). " 05/01/1967 - "Midwest cooperative group evaluation of piposulfan (A-20968) in cancer." 04/01/1968 - "Effect of piposulfan (NSC-47774) on malignant lymphomas and solid tumors." 01/01/1968 - "[Effect of piposulfan (ancyte) in malignant lymphomas and solid tumors]."
2.	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/01/1969 - "Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774)." 05/22/1970 - "[Treatment of chronic myeloid leukemia and lymphoreticular sarcoma with piposulfan]."
3.	Lymphoma (Lymphomas) 04/01/1968 - "Effect of piposulfan (NSC-47774) on malignant lymphomas and solid tumors." 01/01/1968 - "[Effect of piposulfan (ancyte) in malignant lymphomas and solid tumors]."
4.	Sarcoma (Soft Tissue Sarcoma) 05/22/1970 - "[Treatment of chronic myeloid leukemia and lymphoreticular sarcoma with piposulfan]."
5.	Leukemia L1210 01/01/1976 - "The introduction of electron-withdrawing groups into the group R of piposulfan analogs R--SO2--O--X--O--SO2--R substantially increases their antileukemic activity in animal tests (leukemia L 1210). "